Asked by: Darren Paffey (Labour - Southampton Itchen)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will implement a national breast cancer screening awareness campaign to encourage people to attend appointments.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
The NHS Breast Screening Programme has high levels of activity, however NHS England has advised that some women are simply not coming forward for screening. To address this, NHS England is carrying out research into the best approaches to target specific groups that are not coming forward for screening. Evidence suggests approaches such as personalised appointments from a general practitioner (GP), fixed appointment with a date and time, and text messaging reminders are the best ways to engage underserved communities.
In addition, The Help Us Help You national campaign helps to raise awareness of early diagnosis of cancer and encourages people to see their GP sooner. The campaign activity is designed to increase earlier diagnosis of cancer by reducing barriers to seeking earlier help, and by increasing body vigilance and knowledge of key red flag symptoms.
Asked by: Darren Paffey (Labour - Southampton Itchen)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if his Department will (a) review evidence on the health impacts of Primodos and (b) make an assessment of the potential merits of introducing a financial redress scheme for people affected by Primodos.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
We are hugely sympathetic to the families who believe that they have suffered because of using Hormone Pregnancy Tests (HPTs). Currently, the available scientific evidence does not support a causal association between the use HPTs during early pregnancy and adverse pregnancy outcomes.
The Medicines and Healthcare products Regulatory Agency, together with the wider Government, has committed to review any new scientific evidence which comes to light since the conclusions of the 2017 independent Expert Working Group convened by the Commission on Human Medicines.
Due to the unavailability of scientific evidence supporting a causal association between the use of HPTs and adverse pregnancy outcomes, options for financial redress have not been considered further.
Asked by: Darren Paffey (Labour - Southampton Itchen)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the number of NHS prescribers for ADHD medication.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
No specific assessment has been made. It is the responsibility of integrated care boards to make available appropriate provision to meet the health and care needs of their local population, including attention deficit hyperactivity disorder services, in line with relevant National Institute for Health and Care Excellence guidelines.
Asked by: Darren Paffey (Labour - Southampton Itchen)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what progress the Commission for Human Medicines has made on its review of how the risk of sexual dysfunction is communicated to patients; and whether that review includes the potential effects of selective serotonin reuptake inhibitors.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The first meeting of the Expert Working Group (EWG) on antidepressant risk minimisation convened by the Medicine and Healthcare products Regulatory Agency, on the advice of the Commission on Human Medicines, was held on 4 July 2024.
At the initial meeting of the EWG, the terms of reference, scope of work, additional expertise, and plans for patient engagement were discussed. The EWG will consider whether the patient information can be improved and whether additional risk minimisation measures are required for all antidepressants, including selective serotonin reuptake inhibitors.
Asked by: Darren Paffey (Labour - Southampton Itchen)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of trends in the level of health inequalities in Southampton Itchen constituency; and what steps he plans to take to tackle those inequalities.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
As part of our health mission, the Government is committed to ensuring that people live well for longer. This includes tackling the determinants that underpin stark health inequalities, to halve the gap in healthy life expectancy between the richest and poorest regions.
Southampton has 19 Lower Layer Super Output Areas (LSOAs) within the 10% of the most deprived in England. Of the 317 local authorities in England, Southampton is ranked 55th most deprived, based on the average rank of the LSOAs, and 61st most deprived based on the average score of the LSOAs. There has been very little change in relative deprivation levels in Southampton, compared to other local authorities in England, since the last Index of Multiple Deprivation published in 2015. Of the five most deprived neighbourhoods in Southampton, four are within the Southampton Itchen constituency.
Local authorities, both upper tier and unitary, are responsible for commissioning drug and alcohol treatment and recovery services as part of their public health responsibilities, for which Southampton has been allocated £2,069,974 for 2024/25. For those who are also homeless, just over £800,000 has been made available to provide wraparound support and treatment.
Southampton Itchen is one of 75 local authorities with high levels of deprivation receiving funding to improve outcomes for families with babies, as part of the £300 million Family Hubs and Start for Life Programme. The Health and Wellbeing Strategy for Southampton includes an ambition to significantly improve health and wellbeing outcomes, and reduce citywide health inequalities by 2025. It recognises the importance of addressing the wider determinants of health, the conditions into which people are born, live, work, and age. Southampton is also a key member of the Hampshire and Isle of Wight Integrated Care Partnership, working collectively to tackle inequalities in outcomes, experience, and access for the local population.